References
Bataller R, Ginès P, Arroyo V. Practical recommendations for the treatment of ascites and its complications. Drugs 1997 Oct; 54(4): 571–80
Podolsky DK, Isselbacher KJ. Alcohol-related liver disease and cirrhosis. In: Isselbacher KJ, Martin JB, Braunwald E, et al., editors. Harrison’s principles of internal medicine. 13th ed. New York: McGraw-Hill, 1994: 1483–94
Llach J, Ginès P, Arroyo V, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988; 94: 482–7
Titó LI, Ginès P, Arroyo V, et al. Total paracentesis is associated with intravenous albumin in the management of patients with cirrhosis and ascites. Gastroenterology 1990; 98: 146–51
Fernández-Esparrach G, Guevera M, Sort P, et al. Diuretics requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis: a randomized double-blind trial of spironolactone versus placebo. J Hepatol 1997; 26: 614–20
Ginès A, Fernández-Esparrach G, Monescillo A, et al. Randomized trial comparing albumin, Dextran-70 plus polygeline in cirrhotic patients with ascites treated with paracentesis. Gastroenterology 1996; 111: 1002–10
Arroyo V, Navasa M, Rimola A. Spontaneous bacterial peritonitis in liver cirrhosis: treatment and prophylaxis. Infection 1994; 22 Suppl. 3: S1–8
Navasa M. Treatment of spontaneous bacterial peritonitis and other severe bacterial infections in the setting of cirrhosis. In: Arroyo V, Bosch J, Rodés J, editors. Treatments in hepatology. Barcelona: Masson, 1995; 109–13
Runyon B. Diagnosis of bacterial infections in the setting of liver disease. In: Arroyo V, Bosch J, Rodés J, editors. Treatments in hepatology. Barcelona: Masson, 1995; 93–8
Andreu M, Solá R, Sitges-Serra A, et al. Risk factors for spontaneous bacterial peritonitis. Gastroenterology 1993; 104: 1133–8
Titó LI, Rimola A, Ginès P, et al. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988; 8: 27–31
Arroyo V, Rodés J, Gutierrez-Lizarranga MA, et al. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis 1976; 21: 249–56
Arroyo V, Ginès P, Gerbes A, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23: 164–76
Ginès A, Escorsell A, Ginès P, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105: 229–36
Gonwa TA, Wilkinson AH. Liver transplantation in patients with and without hepatorenal syndrome. In: Epstein M, editor. The kidney in liver disease. Philadelphia: Hanmley and Belfus, 1996; 529–42
Ochs A, Rössle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192–7
Guevara M, Ginès P, Fernández-Esparrach G, et al. Reversal of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion [abstract]. J Hepatol 1997; 26: 104
Rights and permissions
About this article
Cite this article
Ascites often associated with poor prognosis in patients with cirrhosis. Drugs Ther. Perspect 12, 8–11 (1998). https://doi.org/10.2165/00042310-199812010-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199812010-00003